Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Cortesi

Showing results (91-100 of 174) with videos related to

Pageof 18
Sort By:
Clinical Endocrinology|December 3, 2019
Thyroid disorders in programmed death 1 inhibitor-treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?Emilia Sbardella, Marta Tenuta, Grazia Sirgiovanni, et al.
Cancer Biology & Therapy|April 24, 2014
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case reportCarlo Capalbo, Paolo Marchetti, Anna Coppa, et al.
Cancer|July 23, 2003
Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatinAnna Ceribelli, Cesare Gridelli, Filippo De Marinis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 6, 2010
Attitude of Italian medical oncologists toward palliative care for patients with advanced cancer: results of the SIO projectSandro Barni, Marco Maltoni, Guido Tuveri, et al.
Investigational New Drugs|February 19, 2013
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective studyLuca Moscetti, Fabrizio Nelli, Maria A Fabbri, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|August 5, 2024
Liver transplantation for organ failure following multiple locoregional treatments for breast cancer metastasisGiammauro Berardi, Valerio Giannelli, Marco Colasanti, et al.
Ebiomedicine|April 27, 2022
Immune effects of CDK4/6 inhibitors in patients with HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer: Relief from immunosuppression is associated with clinical responseFabio Scirocchi, Simone Scagnoli, Andrea Botticelli, et al.
Recenti Progressi in Medicina|December 28, 2020
Long-term outcome of pemetrexed maintenance for advanced nonsquamous non-small-cell lung cancer: a real-world observational cohort studyFabrizio Nelli, Maria Agnese Fabbri, Luca Moscetti, et al.
Frontiers in Oncology|April 17, 2023
Genomic landscape and survival analysis of ctDNA "neo-<i>RAS</i> wild-type" patients with originally <i>RAS</i> mutant metastatic colorectal cancerChiara Nicolazzo, Valentina Magri, Luca Marino, et al.
Cancers|January 21, 2023
Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO)Maurizio Muscaritoli, Gil Bar-Sela, Nicolo Matteo Luca Battisti, et al.
Pageof 18

Showing results (91-100 of 174) with videos related to

Sort By:
Pageof 18
Clinical Endocrinology|December 3, 2019
Thyroid disorders in programmed death 1 inhibitor-treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?Emilia Sbardella, Marta Tenuta, Grazia Sirgiovanni, et al.
Cancer Biology & Therapy|April 24, 2014
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case reportCarlo Capalbo, Paolo Marchetti, Anna Coppa, et al.
Cancer|July 23, 2003
Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatinAnna Ceribelli, Cesare Gridelli, Filippo De Marinis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 6, 2010
Attitude of Italian medical oncologists toward palliative care for patients with advanced cancer: results of the SIO projectSandro Barni, Marco Maltoni, Guido Tuveri, et al.
Investigational New Drugs|February 19, 2013
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective studyLuca Moscetti, Fabrizio Nelli, Maria A Fabbri, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|August 5, 2024
Liver transplantation for organ failure following multiple locoregional treatments for breast cancer metastasisGiammauro Berardi, Valerio Giannelli, Marco Colasanti, et al.
Ebiomedicine|April 27, 2022
Immune effects of CDK4/6 inhibitors in patients with HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer: Relief from immunosuppression is associated with clinical responseFabio Scirocchi, Simone Scagnoli, Andrea Botticelli, et al.
Recenti Progressi in Medicina|December 28, 2020
Long-term outcome of pemetrexed maintenance for advanced nonsquamous non-small-cell lung cancer: a real-world observational cohort studyFabrizio Nelli, Maria Agnese Fabbri, Luca Moscetti, et al.
Frontiers in Oncology|April 17, 2023
Genomic landscape and survival analysis of ctDNA "neo-<i>RAS</i> wild-type" patients with originally <i>RAS</i> mutant metastatic colorectal cancerChiara Nicolazzo, Valentina Magri, Luca Marino, et al.
Cancers|January 21, 2023
Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO)Maurizio Muscaritoli, Gil Bar-Sela, Nicolo Matteo Luca Battisti, et al.
Pageof 18